Richards Group (RIC) Q2 2025 earnings summary

Executive summary

• Q2 2025 performance was impacted by US tariff policies, causing a temporary pullback in US Food & Beverage packaging, while Canadian operations remained strong.

• Cosmetics segment rebounded with strong April and June, offsetting May's tariff headwinds; ecommerce channel launched in late July.

• Healthcare segment integrated DermapenWorld acquisition, driving leverage ratio to 1.1x and expanding global distribution capabilities.

• Operating expenses increased year-over-year due to renewed facility leases and ongoing network consolidation.

• Management remains confident in a strong second half of 2025, supported by new channel launches and recent acquisitions.

Financial highlights

• Revenue for the first half of 2025 rose 2.7% year-over-year to $210.8M, with $3.9M from currency translation and $3.6M from acquisitions.

• Net income for the first half was $8.6M, down from $20.3M in 2024, impacted by $5.6M in exceptional items and a $4.0M mark-to-market loss.

• Adjusted EBITDA for Q2 was $14.6M (13.3% of revenue), down 3.3% year-over-year due to higher lease and administrative costs.

• Gross margin for Q2 was 19.8%, flat year-over-year.

• Distributable cash flow for Q2 was $8.2M, with a payout ratio of 46% on regular distributions.

Outlook and guidance

• Management expects healthcare growth to turn positive in Q3 as negative comps end and acquisition synergies accrue.

• Ecommerce launches in Food & Beverage and Cosmetics are expected to drive additional growth in Q4.

• Lease payments are projected to average $3M per quarter; administrative expenses will rise with acquisitions.

• Surplus distributable cash in Q3 will be used to pay down debt.